My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Published Date

Displaying 21-24 of 24 results for

GO
Search Filters: Massachusetts cancel Pennsylvania cancel

Climate Change and Environmental Justice: A Snapshot of Jurisdiction Activities

Report,
Alaska,
Alabama,
California,
Hawaii,
Massachusetts,
Maryland,
Michigan,
Montana,
Mississippi,
Missouri,
New Mexico,
Oregon,
Pennsylvania,
Rhode Island,
Marshall Islands,
Tennessee,
Utah,
Virgin Islands,
Wisconsin,
Environmental Health,
Climate and Health,
Health Equity,
At-Risk Populations,
Elimination of Disparities,
Race and Public Health

This report is on the overlap of climate change and environmental justice.

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...

Handle with Care: State Newborn Screening Policies

Blog,
Health Policy Update,
Population Health and Prevention,
Women, Infant, and Family Health,
Infant and Child Health,
Policy,
State Health Policy,
Public Health Law,
Arkansas,
California,
Connecticut,
Louisiana,
Maryland,
Massachusetts,
Montana,
New Hampshire,
New Jersey,
New York,
Pennsylvania,
Texas,
Utah,
Wisconsin,
Christina Severin,
Lauren Jones

In the U.S., jurisdictions vary in their newborn screening practices and requirements related to the scope of testing, approach to parental consent, options for blood sample destruction, sample retention periods, and permissible uses of ...